PUBLISHER: Grand View Research | PRODUCT CODE: 1701578
PUBLISHER: Grand View Research | PRODUCT CODE: 1701578
The global hydroxyapatite market size is anticipated to reach USD 3.92 billion by 2030 and is anticipated to expand at a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The hydroxyapatite market is driven by its wide use in bone grafts, dental coatings, and orthopedic implants due to its biocompatibility and osteoconductive properties. The increasing prevalence of osteoporosis, arthritis, and tooth loss, particularly among aging populations, is driving demand.
The nano-sized segment dominated the market with a revenue share of 58.3% in 2024, during the forecast period. The nano-sized segment is growing due to its enhanced bioactivity, high surface area, and superior osteoconductive properties, making it ideal for biomedical applications such as bone grafts, dental coatings, and drug delivery systems. Increasing demand in regenerative medicine, orthopedics, and personal care products is driving market expansion.
The orthopedics segment dominated the market with a revenue share of 56.3% in 2024, during the forecast period. The orthopedics segment is expected to grow as product market is widely used in bone grafts, implants, and coatings for joint replacements due to its biocompatibility and osteoconductive properties. Rising cases of osteoporosis, arthritis, and bone fractures, particularly among aging populations, are fueling demand. Advancements in 3D printing and regenerative medicine are further enhancing hydroxyapatite's role in orthopedic applications.
Asia Pacific dominated the market with a market share of 50.7% in 2024, during the forecast period. The Asia Pacific market is expanding due to increasing demand in orthopedic and dental implants, driven by a rising aging population and improved healthcare infrastructure. Countries such as China, Japan, and India are investing in medical advancements, boosting hydroxyapatite applications in regenerative medicine and biomaterials.
Some of the prominent players in the cryogenic gases market include APS Materials Inc., Zimmer Biomet, Bio-Rad Laboratories Inc., CGbio, Fluidinova, The Lubrizol Corporation, Granulab Sdn. Bhd., SigmaGraft Biomaterials, Berkeley Advanced Biomaterials (GNI Group Ltd), and Taihei Chemica Industrial Co. Ltd.